President George W. Bush keynote speaker at 2018 Cantor Global Healthcare Conference
Howard W. Lutnick, Chairman & CEO of Cantor Fitzgerald, L.P., hosted George W. Bush, 43rd President of the United States, at the 2018 Cantor Global Healthcare Conference in New York City.
One of President Bush’s signature legislative achievements was the Medicare Modernization Act. This engineered a broad structural confirmation of Medicare, including the introduction of an entitlement to prescription drugs for Medicare patients, Medicare Part D.
President Bush shared unique insights from his eight years in office from 2001 to 2009, as well as his thoughts on the future of healthcare provision in the U.S.
The Cantor Fitzgerald Healthcare team is hosting their annual Global Healthcare Conference on October 1-3, 2018 in New York City.
Keynote by President of United States, George W. Bush Monday, October 1st.
The conference is a three-day multitrack event, which will feature over 200 innovative industry leaders from public and private companies for an in-depth discussion of the developments and trends shaping biotechnology, specialty pharmaceuticals, medical technology, healthcare facilities and services, and life sciences tools and diagnostics.
Thought leaders from companies in healthcare will offer their unique insight during company presentations.
This is an invitation only event. Please contact your Cantor Fitzgerald representative for more information.
Abeona Therapeutics Inc. (ABEO)
ACADIA Pharmaceuticals Inc. (ACAD)
Acer Therapeutics Inc.
Aclaris Therapeutics, Inc. (ACRS)
Adicet Bio, Inc.
Aduro BioTech, Inc.
Adverum Biotechnologies, Inc. (ADVM)
Aerie Pharmaceuticals, Inc. (AERI)
Aerpio Pharmaceuticals Inc.
Aimmune Therapeutics, Inc. (AIMT)
Akari Therapeutics, Plc
Albireo Pharma, Inc.
Aldeyra Therapeutics, Inc.
Allena Pharmaceuticals, Inc. (ALNA)
Allscripts Healthcare Solutions Inc. (MDRX)
Alnylam Pharmaceuticals, Inc. (ALNY)
AMAG Pharmaceuticals, Inc. (AMAG)
Amarin Corporation plc (AMRN)
Amneal Pharmaceuticals Inc. (AMRX)
Anavex Life Sciences Corp.
ANI Pharmaceuticals Inc. (ANIP)
Apellis Pharmaceuticals, Inc. (APLS)
Applied Genetic Technologies Corp.
Aptose Biosciences Inc.
Arena Pharmaceuticals, Inc.
Aridis Pharmaceuticals Inc.
Array BioPharma Inc. (ARRY)
Arrowhead Pharmaceuticals, Inc. (ARWR)
Athenex, Inc. (ANTX)
aTyr Pharma Inc.
Aurinia Pharmaceuticals Inc.
Avelas BioSciences, Inc.
AVEO Pharmaceuticals Inc. (AVEO)
Axcella Health, Inc.
AxoGen Inc. (AXGN)
Basilea Pharmaceutica AG (SWX:BSLN)
Bausch Health Companies Inc. (BHC)
Bellicum Pharmaceuticals, Inc.
BELLUS Health Inc.
BioCryst Pharmaceuticals, Inc. (BCRX)
BioDelivery Sciences International
Biohaven Pharmaceutical Holding Company Ltd. (BHVN)
BioMarin Pharmaceutical Inc. (BMRN)
C3J Therapeutics (C3-Jian)
Calithera Biosciences, Inc.
Cara Therapeutics Inc. (CARA)
Catalyst Biosciences, Inc.
Catalyst Pharmaceuticals Inc. (CPRX)
Cell Medica Ltd.
Cellular Biomedicine Group Inc.
Cerus Corporation (CERS)
Cidara Therapeutics, Inc.
Coherus Biosciences, Inc. (CHRS)
Collegium Pharmaceutical, Inc.
Computer Programs and Systems, Inc. (CPSI)
Concert Pharmaceuticals, Inc. (CNCE)
ContraFect Corp. (CFRX)
Corbus Pharmaceuticals Holdings, Inc.
Corcept Therapeutics Incorporated (CORT)
Corium International, Inc.
Correvio Pharma Corporation
Corvus Pharmaceuticals, Inc.
CRH Medical Corporation
Cross Country Healthcare, Inc.
CTI BioPharma Corp.
CymaBay Therapeutics, Inc. (CBAY)
Cytokinetics, Incorporated (CYTK)
CytomX Therapeutics, Inc.
Cytosorbents Corporation (CTSO)
DBV Technologies S.A. (DBVT)
Deciphera Pharmaceuticals, LLC (DCPH)
Dicerna Pharmaceuticals, Inc. (DRNA)
Dova Pharmaceuticals, Inc. (DOVA)
DURECT Corporation (DRRX)
Dynavax Technologies Corporation (DVAX)
Eagle Pharmaceuticals, Inc.
eHealth Inc. (EHTH)
Eiger Biopharmaceuticals Inc.
Ekso Bionics Holdings Inc.
electroCore, Inc. (ECOR)
Eloxx Pharmaceuticals Inc. (ELOX)
Emergent BioSolutions Inc. (EBS)
Emmaus Life Sciences, Inc.
Enzo Biochem, Inc.
Evofem Biosciences, Inc.
Evolus, Inc. (EOLS)
Evotec AG (XTRA:EVT)
Exelixis, Inc. (EXEL)
Fate Therapeutics, Inc.
Fennec Pharmaceuticals Inc.
Flowonix Medical Incorporated
Foamix Pharmaceuticals Ltd
Galapagos NV (GLPG)
Galmed Pharmaceuticals Ltd.
Global Blood Therapeutics, Inc. (GBT)
Globus Medical Inc.
Halozyme Therapeutics, Inc.(HALO)
Harvard Bioscience, Inc.
Health Insurance Innovations, Inc. (HIIQ)
Healthcare Services Group, Inc. (HCSG)
HealthEquity, Inc. (HQY)
Heron Therapeutics, Inc. (HRTX)
HMS Holdings Corp. (HMSY)
HTG Molecular Diagnostics Inc.
IGM Biosciences, Inc.
ImmunoGen, Inc. (IMGN)
Infinity Pharmaceuticals Inc. (INFI)
Inovio Pharmaceuticals, Inc.
Insys Therapeutics, Inc.
Integra LifeSciences Holdings Corp.
Intellia Therapeutics Inc.
Intercept Pharmaceuticals, Inc. (ICPT)
Intra-Cellular Therapies, Inc. (ITCI)
Iovance Biotherapeutics Inc. (IOVA)
Iterum Therapeutics PLC
Jounce Therapeutics, Inc.
Kala Pharmaceuticals, Inc.
Kalvista Pharmaceuticals Inc. (KALV)
Karyopharm Therapeutics Inc. (KPTI)
Keryx Biopharmaceuticals (KERX)
Knight Therapeutics Inc. (TSX:GUD)
Krystal Biotech Inc.
Lantheus Holdings, Inc. (LNTH)
Leap Therapeutics Inc.
LeMaitre Vascular, Inc.
Lexicon Pharmaceuticals, Inc. (LXRX)
Mallinckrodt Pharmaceuticals (MNK)
MDxHealth SA (ENXTBR:MDXH)
Melinta Therapeutics, Inc. (MLNT)
Merit Medical Systems, Inc. (MMSI)
Mersana Therapeutics, Inc. (MRSN)
Molecular Templates, Inc.
MyoKardia Inc. (MYOK)
Nabriva Therapeutics plc
NeoGenomics, Inc. (NEO)
Neon Therapeutics Inc.
Neos Therapeutics, Inc.
NewLink Genetics Corporation
Novavax, Inc. (NVAX)
Ocular Therapeutix, Inc.
Omeros Corporation (OMER)
OncoMed Pharmaceuticals Inc.
OncoSec Medical Incorporated (ONCS)
Opiant Pharmaceuticals, Inc.
OptiNose US Inc. (OPTN)
OraSure Technologies (OSUR)
Ovid Therapeutics Inc. (OVID)
Pacific Biosciences of California, Inc.
PDL BioPharma, Inc.
Pieris Pharmaceuticals, Inc.
Pliant Therapeutics, Inc.
PolarityTE, Inc. (PTE)
Progenics Pharmaceuticals, Inc. (PGNX)
ProMetic Life Sciences Inc.
Protagonist Therapeutics, Inc.
Proteostasis Therapeutics, Inc.
PsiOxus Therapeutics Ltd
Pulse Biosciences, Inc.
Puma Biotechnology, Inc.
Quotient Limited (QTNT)
R1 RCM Inc. (RCM)
Ra Pharmaceuticals, Inc. (RARX)
Reata Pharmaceuticals, Inc. (RETA)
Regulus Therapeutics Inc.
Revance Therapeutics, Inc. (RVNC)
Rigel Pharmaceuticals, Inc. (RIGL)
RTI Surgical, Inc.
Sangamo Therapeutics, Inc.
SeaSpine Holdings Corporation
Selecta Biosciences, Inc. (SELB)
SELLAS Life Sciences Group, Inc.
SIGA Technologies, Inc.
Sophiris Bio Inc.
Spark Therapeutics Inc.
Spectrum Pharmaceuticals, Inc. (SPPI)
Spring Bank Pharmaceuticals, Inc. (SBPH)
Stemline Therapeutics, Inc.
Strongbridge Biopharma plc (SBBP)
Sunesis Pharmaceuticals, Inc.
Supernus Pharmaceuticals, Inc. (SUPN)
Syndax Pharmaceuticals, Inc.
Syros Pharmaceuticals, Inc.
T2 Biosystems, Inc.
Tactile Medical (TCMD)
Taiwan Liposome Company, Ltd.
Tarveda Therapeutics Inc.
TESARO Inc. (TSRO)
Tetraphase Pharmaceuticals Inc. (TTPH)
TG Therapeutics, Inc. (TGTX)
TherapeuticsMD, Inc. (TXMD)
Theratechnologies Inc. (TSX:TH)
Theravance Biopharma, Inc. (TBPH)
Tmunity Therapeutics, Inc.
TransEnterix, Inc. (AMEX:TRXC)
uniQure N.V. (QURE)
Unity Biotechnology, Inc.
Vanda Pharmaceuticals Inc. (VNDA)
Verastem, Inc. (VSTM)
Vericel Corporation (VCEL)
ViewRay, Inc. (VRAY)
Viking Therapeutics, Inc.
X4 Pharmaceuticals Inc.
Xencor, Inc. (XNCR)
ZIOPHARM Oncology, Inc.
Zoetis Inc. (ZTS)
Zomedica Pharmaceuticals Corp.
Zynerba Pharmaceuticals, Inc. (ZYNE)